Cdc42 is a key regulator of b cell differentiation and is required for antiviral humoral immunity

62Citations
Citations of this article
128Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The small Rho GTPase Cdc42, known to interact with Wiskott-Aldrich syndrome (WAS) protein, is an important regulator of actin remodeling. Here, we show that genetic ablation of Cdc42 exclusively in the B cell lineage is sufficient to render mice unable to mount antibody responses. Indeed Cdc42-deficient mice are incapable of forming germinal centers or generating plasma B cells upon either viral infection or immunization. Such severe immune deficiency is caused by multiple and profound B cell abnormalities, including early blocks during B cell development; impaired antigen-driven BCR signaling and actin remodeling; defective antigen presentation and in vivo interaction with T cells; and a severe B cell-intrinsic block in plasma cell differentiation. Thus, our study presents a new perspective on Cdc42 as key regulator of B cell physiology.

Cite

CITATION STYLE

APA

Burbage, M., Keppler, S. J., Gasparrini, F., Martínez-Martín, N., Gaya, M., Feest, C., … Batista, F. D. (2015). Cdc42 is a key regulator of b cell differentiation and is required for antiviral humoral immunity. Journal of Experimental Medicine, 212(1), 53–72. https://doi.org/10.1084/jem.20141143

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free